Last reviewed · How we verify

MMR followed by YF — Competitive Intelligence Brief

MMR followed by YF (MMR followed by YF) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated viral vaccine combination. Area: Immunology / Infectious Disease.

marketed Live attenuated viral vaccine combination Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

MMR followed by YF (MMR followed by YF) — Alba Maria Ropero. MMR vaccine primes immune response against measles, mumps, and rubella; yellow fever vaccine then boosts immunity against yellow fever virus.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
MMR followed by YF TARGET MMR followed by YF Alba Maria Ropero marketed Live attenuated viral vaccine combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated viral vaccine combination class)

  1. Alba Maria Ropero · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MMR followed by YF — Competitive Intelligence Brief. https://druglandscape.com/ci/mmr-followed-by-yf. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: